News

Even as artificial intelligence has made strides in summarizing research papers or solving mathematical problems, ...
HSBC Innovation Banking, a subsidiary of Europe’s biggest lender, hailed the UK’s enterprise value in its latest innovation ...
Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...
NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
According to Dealroom, in Q1 2025, European startups have secured $15.8B through nearly 1,600 funding rounds. From AI and fintech to clean energy and biotech, startups have attracted large amounts of ...
Retailers and brands have turned to Vietnam to manufacture goods from sneakers to couches while moving some or all production ...
Dealbreaker on MSN14d
An AI Biotech Hauls In $600M
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.
Isomorphic Labs, a young company whose artificial intelligence technology for drug research has already landed partnerships with big pharmaceutical companies, unveiled $600 million in new ...
As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...
Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...